QU496 - Provision of Cost Benefit Analysis of Carrier Screening for Genetic Disorders

Concepts

• analysis services
• west midlands
• birmingham city council
• cost benefit analysis
• data analysis
• estimate of service costs
• genetic disorders
• economic benefits
• genetic autosomal recessive screening
• provision of screening women

Location

Description

Birmingham City Council requires a supplier for the provision of a Desk Based Report on the Cost Benefit Analysis (CBA) of Genetic Autosomal Recessive Screening. This will be used to inform the action plan of the Birmingham Perinatal and Infant Mortality Strategy. We would like the report to include an estimate of service costs regarding stillbirths, perinatal mortality, infant mortality and lifetime associated with those that survive infancy. Costs can be based on historic service models in addition the estimates for the thresholds of cost effectiveness for each of the above. The costs should be specified for the NHS, social services and the wider costs to society. For the purposes of developing our Peri-natal and Infant Mortality Strategy, Birmingham City Council (BCC) Public Health requires an evaluation that compares the cost of screening for autosomal recessive conditions with the economic benefits accruing from changes in the prevalence rates of stillbirths, peri-natal and infant mortality and health outcomes. The cost benefits should include the financial savings to services in the health, social care and education sectors and the wider society. The CBA needs to be based on provision of screening women who are planning a pregnancy and the women and partners who are considered to be at risk from a genetic disorder with X-linked genetic conditions with a panel screening for multiple conditions. The CBA needs to consider a Genetic Counselling component and the cost considerations for this element.

CPV Codes

• 71620000 - Analysis services
• 72316000 - Data analysis services
• 85144000 - Residential health facilities services
• 85147000 - Company health services
• 85323000 - Community health services

Indicators

• Contract is suitable for SMEs.

Other Information

Your proposal must: o Describe your methodology for writing this report to include planning, mapping, modelling and reporting o Provide a breakdown of total costs including key expenditure anticipated to deliver the project The contract to undertake the CBA of autosomal recessive screening will be for a period of 6 months commencing 13th September 2021. The Council will be using its free to use e-tendering system (in-tend) for the administration of this procurement process and potential suppliers must register with the system to be able to express an interest. If you wish to express an interest in this opportunity please click on the following link to access https://in-tendhost.co.uk/birminghamcc/ and submit your details to register. You will then be sent details on how to log on which will enable you to download all relevant tender documentation. If you are unable to register with In-tend or have any questions or problems on how to use this web site please either email us at: cps@birmingham.gov.uk or call CPS Helpdesk on 0121 464 8000. Your completed tender submission should be returned by noon on 20th August 2021 via the 'in-tend' system https://in-tendhost.co.uk/birminghamcc If you are interested in tendering please click on the following link to access Birmingham City Council's tender Portal. Delivery Notes Birmingham Is a Recurrent Procurement Type? : No Additional information on how to apply for this contract https://in-tendhost.co.uk/birminghamcc/aspx/